Boehringer Ingelheim and Tempus Forge Multi-Year AI-Driven Oncology Drug Development Partnership
Germany-based pharmaceutical major Boehringer Ingelheim has entered into a multi-year strategic collaboration with Tempus (NASDAQ:...
NASDAQ: TEM
AstraZeneca Expands AI Partnership with Tempus AI and Pathos AI for Oncology Research
UK pharmaceutical leader AstraZeneca (AZ, NASDAQ: AZN) has expanded its collaboration with US-based Tempus AI,...
Illumina and Tempus AI Collaborate to Advance Next-Generation Sequencing in Clinical Practice
US major Illumina (NASDAQ: ILMN) and Tempus AI, Inc. (NASDAQ: TEM) are joining forces to...